# Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-pd-l-1-for-kras-mutant-advanced-non-small-cell-lung-cancers-a-meta-analysis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thierry Landre,G. Justeau,Jean‐Baptiste Assié,Kader Chouahnia,Claire Davoine,Chérifa Taleb,C. Chouaïd,Boris Duchemann |
| Citations | 94 |
| DOI | 10.1007/s00262-021-03031-1 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/10992001 |
| OpenAlex ID | https://openalex.org/W3190297823 |
| PMID | 34378081 |
| Type | review |
| Year | 2021 |

## Paper authors

- [Boris Duchemann](https://scholariq.org/researchers/boris-duchemann/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.